US+1 646-781-8004
Redding, California - December 6, 2022

Cell Culture Market Worth $48.63 Billion by 2029

Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, academic)—Global Forecast to 2029

Meticulous Research®—a leading market research company, published a research report titled, Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, Academic) - Global Forecast to 2029.’

According to this latest publication from Meticulous Research®, the cell culture market is expected to grow at a CAGR of 11.7% during the forecast period 2022–2029, to reach $48.63 billion by 2029. The growth in biopharmaceutical market, increasing prevalence of chronic diseases, growing demand for monoclonal antibodies, increase in research funding, and rising adoption of single-use technologies are the factors driving the growth of this market.

Additionally, the growing adoption of 3D cell culture and personalized medicines is expected to offer significant growth opportunities for players in this market.

The Impact of the COVID-19 Pandemic on Cell Culture-based Research Activities

Understanding the kinetics of infectious virus and its potential for transmission was the crucial guide for preventing infection and its control strategies during the initial spread of the COVID-19 virus. Subsequently, researchers across the globe were trying to understand the biology of different virus variants to develop new therapeutic methods. This study process started in laboratory experiments to understand whether a drug can stop the virus from replicating in cells in a dish or whether a vaccine is effective against the virus. The experiments provided insights for developing treatments, vaccines, and diagnostic tools. On February 4, 2020, the Centers for Disease Control and Prevention (CDC) shipped the SARS-CoV-2 virus strain to the Biodefense and Emerging Infections Research Resources Repository, which was made available globally for researchers in the scientific and medical community to use the strain in their studies.

In vitro cell culture models played an important part in studying COVID-19-related projects. Human lung epithelium models are currently being tested as a platform for COVID-19 research. The other models used are normal human bronchial epithelial cells, normal human small airway epithelial cells, tissue-specific extracellular matrices, and airway primary endothelial cells. The major areas of COVID-19 research were antiviral research, vaccine development, pathogenesis research, and virus stability research. Hence, the pandemic positively impacted the growth of cell culture products.

The cell culture market segmented by Product [Consumables (Media {Cell Culture Media, by Form–Dry Form, Liquid Form}, {Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media}, {Cell Culture Media; Source- Serum-free Media, Chemically Defined Media, Classical Media, Xeno-free/Animal Component Free}), Reagents (Growth Factors And Cytokines, Cryoprotective Reagents, Antibiotics/Antimycotics, Cell Dissociation Reagents, Buffers, Balanced Salt Solutions, Attachment And Matrix Factors, Other Cell Culture Reagents), Cells And Cell Lines, Sera (Fetal Bovine Serum, Other Sera Types), Cell Culture Vessels (Cell Culture Dishes, Cell Culture Plates {6 to 24-well Plates, 48-well Plates, 96 to 384-well Plates}, Cell Culture Flasks, Roller Bottles, Other Cell Culture Vessels) Equipment (Bioreactors, Biosafety Cabinets, Incubators, Cryopreservation Containers, Refrigerators And Freezers, Sterilizers, Microscopes, Centrifuges, Cell Counters, Water Baths, Other Equipment)]; Application [Bioproduction (Monoclonal Antibody Production, Therapeutic Protein Production, Vaccine Production, Cell And Gene Therapy)], Drug Screening & Development, Cancer Research, Stem Cell Research, Other Applications); End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Other End Users); and Geography. The study also evaluates industry competitors and analyzes regional and country-level markets.

Based on product, the cell culture market is segmented into consumables and equipment. In 2022, the consumables segment is estimated to account for the largest share of the cell culture market. The major factor contributing to the large market share of this segment is the increasing need for cell culture techniques for various applications, which in return leads to the frequent use of consumables. Various consumables such as media, reagents, sera, and cell lines are the most commonly used consumables required at every stage of the cell culture process.

Based on application, the cell culture market is segmented into bioproduction, cancer research, drug screening & development, stem cell research, and other applications. In 2022, the bioproduction segment is estimated to account for the largest share of the cell culture market. The major factors contributing to the large market share of this segment are the growing demand for biopharmaceutical products such as monoclonal antibodies, vaccines, therapeutic proteins, and gene therapies.

Based on end user, the cell culture market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and other end users. In 2022, the pharmaceutical & biotechnology companies’ segment is estimated to account for the largest share of the cell culture market. Major factors contributing to the growth of this segment are the presence of large biotech companies and the growing number of start-ups, companies expanding their production and cell culture facilities, and increased focus on research activities.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America and the Middle East & Africa. In 2022, North America is estimated to dominate the cell culture market, followed by Europe and Asia-Pacific. The well-established healthcare system in the region, increasing adoption of advanced technologies, growing prevalence of non-communicable diseases, growing pharmaceutical research, ongoing capacity expansion by biopharmaceutical manufacturers, and presence of major players propel the growth of the cell culture market in North America.

Key Players:

The key players operating in the cell culture market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Cytiva (U.S.), Lonza Group Ltd. (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), Avantor, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), Eppendorf SE (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Getinge AB (Sweden),  Greiner Bio-One GmbH (Austria), and Miltenyi Biotec B.V. & Co. KG (Germany).

Download Free Sample PDf Copy Here:

Key questions answered in the report-

  • Which are the high-growth market segments in terms of product, application, end user, and region/countries?
  • What was the historical market for cell culture across the globe?
  • What are the market forecasts and estimates for the period 2022–2029?
  • What are the major drivers, restraints, opportunities, and challenges in the cell culture market?
  • Who are the major players in the cell culture market?
  • What is the competitive landscape, and who are the market leaders in the cell culture market?
  • What are the recent developments in the cell culture market?

Contact Us:
Meticulous Research®
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn-

Recommended Readings

Related Reports
Share this on:
Save PDF
  Download Free Sample Report
Table Of Content
Download Free Sample Report

Meticulous Research
+1 646-781-8004
Meticulous Research
Meticulous Research
Subscribe to get the latest industry updates